Healthcare provider profile · identity verified

Greg Alan Andrle, DO

Family Practice · CAMBRIDGE, MN · NPI 1770657884

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	502	139
Lisinopril	Lisinopril	466	129
Omeprazole	Omeprazole	295	78
Losartan Potassium	Losartan Potassium	279	82
Metoprolol Succinate	Metoprolol Succinate	271	76
Hydrochlorothiazide	Hydrochlorothiazide	268	76
Amlodipine Besylate	Amlodipine Besylate	253	71
Trazodone Hcl	Trazodone Hcl	215	61
Tamsulosin Hcl	Tamsulosin Hcl	213	55
Metformin Hcl Er	Metformin Hcl	209	59
Levothyroxine Sodium	Levothyroxine Sodium	200	50
Pantoprazole Sodium	Pantoprazole Sodium	193	44
Gabapentin	Gabapentin	187	46
Rosuvastatin Calcium	Rosuvastatin Calcium	181	53
Simvastatin	Simvastatin	181	46
Montelukast Sodium	Montelukast Sodium	157	41
Metoprolol Tartrate	Metoprolol Tartrate	155	42
Furosemide	Furosemide	131	43
Clopidogrel	Clopidogrel Bisulfate	112	30
Metformin Hcl	Metformin Hcl	110	34
Eliquis	Apixaban	108	32
Pregabalin	Pregabalin	103	18
Escitalopram Oxalate	Escitalopram Oxalate	99	27
Albuterol Sulfate Hfa	Albuterol Sulfate	96	45
Allopurinol	Allopurinol	92	24
Warfarin Sodium	Warfarin Sodium	92	24
Famotidine	Famotidine	87	24
Fluoxetine Hcl	Fluoxetine Hcl	83	25
Glipizide	Glipizide	82	21
Duloxetine Hcl	Duloxetine Hcl	80	19
Azithromycin	Azithromycin	79	47
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	78	23
Prednisone	Prednisone	76	40
Atenolol	Atenolol	75	21
Glipizide Er	Glipizide	75	19
Carvedilol	Carvedilol	74	23
Meloxicam	Meloxicam	73	28
Sertraline Hcl	Sertraline Hcl	70	22
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	67	19
Doxazosin Mesylate	Doxazosin Mesylate	66	13
Tramadol Hcl	Tramadol Hcl	66	suppressed
Ventolin Hfa	Albuterol Sulfate	65	17
Citalopram Hbr	Citalopram Hydrobromide	53	17
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	53	12
Ozempic	Semaglutide	51	13
Triamcinolone Acetonide	Triamcinolone Acetonide	50	26
Nystatin	Nystatin	49	24
Esomeprazole Magnesium	Esomeprazole Magnesium	47	20
Finasteride	Finasteride	45	13
Hydroxyzine Hcl	Hydroxyzine Hcl	45	17
Donepezil Hcl	Donepezil Hcl	43	suppressed
Potassium Chloride	Potassium Chloride	43	15
Pravastatin Sodium	Pravastatin Sodium	43	11
Amoxicillin	Amoxicillin	41	26
Fluticasone Propionate	Fluticasone Propionate	41	26
Spironolactone	Spironolactone	40	13
Celecoxib	Celecoxib	39	13
Ibuprofen	Ibuprofen	39	15
Ropinirole Hcl	Ropinirole Hcl	39	11
Cephalexin	Cephalexin	38	23
Ezetimibe	Ezetimibe	37	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	37	11
Paroxetine Hcl	Paroxetine Hcl	36	suppressed
Bupropion Xl	Bupropion Hcl	32	12
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	32	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	31	suppressed
Januvia	Sitagliptin Phosphate	30	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	30	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	29	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	27	23
Lansoprazole	Lansoprazole	27	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	27	13
Torsemide	Torsemide	27	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	26	14
Oxycodone Hcl	Oxycodone Hcl	26	11
Nitroglycerin	Nitroglycerin	25	21
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	24	suppressed
Memantine Hcl	Memantine Hcl	24	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	23	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	23	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	23	suppressed
Mounjaro	Tirzepatide	23	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	23	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	23	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	22	suppressed
Ondansetron Odt	Ondansetron	22	15
Propranolol Hcl Er	Propranolol Hcl	22	suppressed
Scopolamine	Scopolamine	22	suppressed
Alprazolam	Alprazolam	21	suppressed
Clindamycin Hcl	Clindamycin Hcl	21	suppressed
Clonazepam	Clonazepam	20	suppressed
Lamotrigine	Lamotrigine	20	suppressed
Methocarbamol	Methocarbamol	20	11
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	20	suppressed
Tizanidine Hcl	Tizanidine Hcl	20	suppressed
Aripiprazole	Aripiprazole	19	suppressed
Buspirone Hcl	Buspirone Hcl	19	suppressed
Levetiracetam	Levetiracetam	19	suppressed
Mirtazapine	Mirtazapine	19	suppressed
Baclofen	Baclofen	18	suppressed
Lovastatin	Lovastatin	18	suppressed
Trulicity	Dulaglutide	18	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Fluconazole	Fluconazole	17	suppressed
Risperidone	Risperidone	17	suppressed
Synthroid	Levothyroxine Sodium	17	suppressed
Hydralazine Hcl	Hydralazine Hcl	16	suppressed
Lorazepam	Lorazepam	16	suppressed
Propranolol Hcl	Propranolol Hcl	16	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	16	suppressed
Repatha Sureclick	Evolocumab	15	suppressed
Sucralfate	Sucralfate	15	suppressed
Acyclovir	Acyclovir	14	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	14	suppressed
Fentanyl	Fentanyl	13	suppressed
Irbesartan	Irbesartan	13	suppressed
Naproxen	Naproxen	13	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	12	suppressed
Bupropion Hcl Sr	Bupropion Hcl	12	suppressed
Enbrel Sureclick	Etanercept	12	suppressed
Hydrocortisone	Hydrocortisone	12	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	12	suppressed
Jardiance	Empagliflozin	12	suppressed
Rivastigmine	Rivastigmine Tartrate	12	suppressed
Sotalol	Sotalol Hcl	12	suppressed
Terazosin Hcl	Terazosin Hcl	12	suppressed
Brilinta	Ticagrelor	11	suppressed
Chlorthalidone	Chlorthalidone	11	suppressed
Latanoprost	Latanoprost	11	suppressed
Levalbuterol Tartrate Hfa	Levalbuterol Tartrate	11	suppressed
Ranolazine Er	Ranolazine	11	suppressed
Tresiba Flextouch U-200	Insulin Degludec	11	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error